PALISADE BIO, INC.: 10-Q filed 2014-08-08

Name: PALISADE BIO, INC.: 10-Q filed 2014-08-08
Creator: PALISADE BIO, INC.

What PALISADE BIO, INC. reported in its quarterly report filed 2014-08-08 (fiscal Q2 2014): 25 published measures, 70 facts as tagged in accession 0001144204-14-047843.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-08-08
Fiscal period: fiscal Q2 2014
Accession: 0001144204-14-047843 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-06-30	32,628,549	USD
At 2013-12-31	19,413,536	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-06-30	8,599,857	USD
At 2013-12-31	10,995,337	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-06-30	24,028,692	USD
At 2013-12-31	8,418,199	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-06-30	15,232,456	USD
At 2013-12-31	16,846,052	USD
At 2013-06-30	11,166,077	USD
At 2012-12-31	7,443,773	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-6,751,282	USD	91
2014-01-01 to 2014-06-30	-12,670,339	USD	181
2013-04-01 to 2013-06-30	-6,251,630	USD	91
2013-01-01 to 2013-06-30	-9,841,717	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	145,091	USD	181
2013-01-01 to 2013-06-30	5,392	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	5,000	USD	91
2014-01-01 to 2014-06-30	9,167	USD	181
2013-04-01 to 2013-06-30	2,500	USD	91
2013-01-01 to 2013-06-30	105,000	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-06-30	-141,096,376	USD
At 2013-12-31	-128,426,037	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-06-30	310,050	USD
At 2013-12-31	230,971	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	541,026	USD	91
2014-01-01 to 2014-06-30	2,982,025	USD	181
2013-04-01 to 2013-06-30	596,576	USD	91
2013-01-01 to 2013-06-30	1,073,287	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-3,511,238	USD	91
2014-01-01 to 2014-06-30	-8,688,139	USD	181
2013-04-01 to 2013-06-30	-3,235,602	USD	91
2013-01-01 to 2013-06-30	-6,127,382	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-06-30	30,842,430	USD
At 2013-12-31	17,619,119	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	397,616	USD	91
2014-01-01 to 2014-06-30	830,357	USD	181
2013-04-01 to 2013-06-30	439,271	USD	91
2013-01-01 to 2013-06-30	487,528	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-06-30	4,991,166	USD
At 2013-12-31	5,936,132	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-06-30	24,468	USD
At 2013-12-31	10,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	3,516,238	USD	91
2014-01-01 to 2014-06-30	8,697,306	USD	181
2013-04-01 to 2013-06-30	3,238,102	USD	91
2013-01-01 to 2013-06-30	6,232,382	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	1,947,558	USD	91
2014-01-01 to 2014-06-30	3,518,779	USD	181
2013-04-01 to 2013-06-30	1,906,387	USD	91
2013-01-01 to 2013-06-30	3,654,734	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-06-30	86,837,455	shares
At 2013-12-31	77,886,031	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-06-30	164,250,586	USD
At 2013-12-31	136,058,135	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-06-30	6,107	USD
At 2013-12-31	7,241	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2014-06-30	1,247,498	USD
At 2013-12-31	1,137,701	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-06-30	58,859	USD
At 2013-12-31	64,897	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	1,481,948	USD	91
2014-01-01 to 2014-06-30	5,001,307	USD	181
2013-04-01 to 2013-06-30	1,281,210	USD	91
2013-01-01 to 2013-06-30	2,477,050	USD	181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-3,240,044	USD	91
2014-01-01 to 2014-06-30	-3,982,200	USD	181
2013-04-01 to 2013-06-30	-3,016,028	USD	91
2013-01-01 to 2013-06-30	-3,714,335	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	14,468	USD	181
2013-01-01 to 2013-06-30	53,422	USD	181

Inspect the source

Entity: PALISADE BIO, INC. / CIK 0001357459
Captured: 2026-09-20T07:55:46.162Z
SEC response SHA-256: 1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))